PeerVoice Digestive Diseases Audio

PeerVoice is committed to producing and distributing evidence-based, independently-created medical education in Digestive Diseases that is designed to positively impact patient care. Activities can either be accredited or non-accredited but are always driven by the learning and practice needs of healthcare professionals. Learn more at: https://peervoice.com.

39 episodes

1mo ago latest

monthly cadence

English language

▶ Play latestRSS feed Website Science Health Fitness Medicine Education

https://c.peervoice.com/podcast/xml/gastroenterology_audio.xml

Episodes 40

Hannele Yki-Järvinen, MD, FRCP - Recognising and Referring Individuals With MASH: Practical Pathways for Our Endocrinology Practices
2d ago · 38:31
For the complete activity, including supporting material, please visit https://www.peervoice.com/CTG860. Presented by Hannele Yki-Järvinen, MD, FRCP and Jeremy Tomlinson, MD, PhD, FRCP. Learning Objectives: Identify individuals who warrant evaluation for metabolic dysfunction-associated steatohepatitis (MASH) with fibrosis based on the presence of cardiometabolic risk factors; Apply available non-invasive scoring systems such as the Fibrosis-4 (FIB-4) Index to predict presence of hepatic fibrosis; Use the outcomes of non-invasive tests to guide referral of individuals to specialist care for su
One Disease, Many Clinical Presentations: Why and How to Spot Acute Hepatic Porphyria in Different Healthcare Settings
1mo ago · 26:33
For the complete activity, including supporting material, please visit https://www.peervoice.com/GVP860. Presented by Miguel Bajouco, MD, MSc; David Cassiman, MD, PhD; Rebecca Karp Leaf, MD; Katherine Pocius, MD, MPH; and Paulo Lima Serrano, MD, PhD Learning Objectives: Recognise the importance of early suspicion of acute hepatic porphyria (AHP) in reducing diagnostic delays and improving outcomes; Explain how to test for AHP in patients with indicative clinical symptoms and signs; Analyse presenting symptoms and clinical history to determine when AHP should be strongly suspected and diagnosti
John Friedewald, MD, FASN, FAST - Breakthroughs and Buzz From Boston: Key Takeaways for the Kidney Transplant Community
1mo ago · 17:39
For the complete activity, including supporting material, please visit https://www.peervoice.com/WBP860. Presented by John Friedewald, MD, FASN, FAST Learning Objectives: Identify emerging data that can be applied in current clinical practice to optimize the care and outcomes of kidney transplant recipients; Evaluate investigational immunosuppressants, therapies and technologies, and overall research trends to anticipate potential shifts in future standards of care in kidney transplantation.
Sven Francque, MD, PhD - The Gastroenterologist’s Guide to Finding and Managing MASH With Fibrosis: Practical Strategies for Everyday Practice
3mo ago · 35:42
For the complete activity, including supporting material, please visit https://www.peervoice.com/FAK860. Presented by Sven Francque, MD, PhD; and José Luis Calleja Panero, MD, PhD. Learning Objectives: Recall the rationale for prompt identification of metabolic dysfunction-associated steatohepatitis (MASH) in gastroenterology patients, including the high prevalence in specific patient groups, the risk of progression, and the availability of novel treatments; Use recommended non-invasive blood- and image-based methods to evaluate for evidence of steatosis and fibrosis among individuals with car
Javier Ampuero, MD, PhD - Making MASH a Priority in Our Gastroenterology Practices: Why We Should and How We Can
4mo ago · 20:02
For the complete activity, including supporting material, please visit https://www.peervoice.com/PXK860. Presented by Javier Ampuero, MD, PhD and Meena B. Bansal, MD, FAASLD. Learning Objectives: Explain the rationale for prompt identification and active management of individuals with metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis, based on the increased risk of adverse liver outcomes associated with progression of fibrosis; Evaluate the impact of novel MASH-targeted therapies, such as THR-β agonists, on the underlying pathophysiology and progression of the disease; Ident
Jörn M. Schattenberg, MD - Cases in Contemporary MASH Management: Expert Insights on the Practical Integration of Disease-Specific Pharmacotherapy
8mo ago · 34:23
Visit https://www.peervoice.com/NVE860 to view the entire programme with slides. After completing “Jörn M. Schattenberg, MD - Cases in Contemporary MASH Management: Expert Insights on the Practical Integration of Disease-Specific Pharmacotherapy”, participants will be able to: Evaluate current evidence and practice guidance for use of liver-directed pharmacotherapy for management of metabolic dysfunction-associated steatohepatitis (MASH); Identify individuals with non-cirrhotic MASH and moderate to advanced (F2-F3) fibrosis who may benefit from timely initiation of disease-specific pharmacothe
Naim Alkhouri, MD, FAASLD, DABOM - Don’t Wait, and Look Beyond Weight: The Growing Case for Urgent and Comprehensive Management of MASH
8mo ago · 20:31
Visit https://www.peervoice.com/NBF860 to view the entire programme with slides. After completing “Naim Alkhouri, MD, FAASLD, DABOM - Don’t Wait, and Look Beyond Weight: The Growing Case for Urgent and Comprehensive Management of MASH”, participants will be able to: Explain the rationale for prompt identification and active management of individuals with metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis, based on the increased risk of adverse liver outcomes associated with progression of fibrosis; Recall the mechanistic and evidence-based rationale for THR-β agonists as dise
Kris V. Kowdley, MD - Advancing the Management of Cholestatic Liver Disease: Optimizing Treatment Pathways and Novel Therapies
8mo ago · 1:17:30
Visit https://www.peervoice.com/XYZ860 to view the entire programme with slides. After completing “Kris V. Kowdley, MD - Advancing the Management of Cholestatic Liver Disease: Optimizing Treatment Pathways and Novel Therapies”, participants will be able to: Describe the clinical presentation and biochemical abnormalities in patients with primary biliary cholangitis (PBC) and progressive familial intrahepatic cholestasis (PFIC); Utilize practical approaches, including evidence-based tools, to evaluate and predict response to therapy and facilitate treatment decision-making in patients with chol
Marla C. Dubinsky, MD / David T. Rubin, MD - TNF Inhibitors in Inflammatory Bowel Disease: How Can We Realize Opportunities to Optimize Clinical and Patient Outcomes?
1y ago · 57:01
Visit https://www.peervoice.com/XAD860 to view the entire programme with slides. After completing “Marla C. Dubinsky, MD / David T. Rubin, MD - TNF Inhibitors in Inflammatory Bowel Disease: How Can We Realize Opportunities to Optimize Clinical and Patient Outcomes?”, participants will be able to: Recall the evidence of the impact of tumor necrosis factor (TNF) inhibitors on endoscopic outcomes in patients with inflammatory bowel disease (IBD); Use clinical data to illustrate the potential benefits of early intervention with; TNF inhibitors in patients with IBD; Explain the importance of mainta
Albrecht Stenzinger, MD - Optimising the Molecular Profiling Journey for Patients With CCA: Applying Best Practices and Avoiding Pitfalls
1y ago · 25:39
Visit https://www.peervoice.com/YDE860 to view the entire programme with slides. After completing “Albrecht Stenzinger, MD - Optimising the Molecular Profiling Journey for Patients With CCA: Applying Best Practices and Avoiding Pitfalls”, participants will be able to: Explain the rationale and current guidelines for molecular testing and targeted treatment of cholangiocarcinoma (CCA); Identify best practices for pre-analytic sample management in CCA, including potential challenges associated with specific sample sources; and Recognise current recommendations related to selection of molecular p
Olivier Bonnot, MD, PhD - Acute Psychosis: When to Suspect Acute Hepatic Porphyria
1y ago · 17:58
Visit https://www.peervoice.com/YQY860 to view the entire programme with slides. After completing “Olivier Bonnot, MD, PhD - Acute Psychosis: When to Suspect Acute Hepatic Porphyria”, participants will be able to: Recognise acute hepatic porphyria (AHP) in patients with acute psychosis; Identify patients with psychological symptoms who should be screened for AHP; and Describe the importance of a multidisciplinary team approach in the management of patients with AHP.
Darren M. Brenner / Benoît Coffin - If I'd Known Then What I Know Now: Recognising My First AHP Patient
1y ago · 18:40
Visit https://www.peervoice.com/UDS860 to view the entire programme with slides. After completing “Darren M. Brenner / Benoît Coffin - If I'd Known Then What I Know Now: Recognising My First AHP Patient”, participants will be able to: Describe uncommon causes of unexplained abdominal pain; Recognise acute hepatic porphyria (AHP) in patients with severe abdominal pain; and Discuss the importance of random (spot) urine testing in patients with suspected AHP.
Darren M. Brenner, MD - If I'd Known Then What I Know Now: Recognising My First AHP Patient (Rebroadcast)
1y ago · 18:37
Visit https://www.peervoice.com/HJY860 to view the entire programme with slides. After completing “Darren M. Brenner, MD - If I'd Known Then What I Know Now: Recognising My First AHP Patient (Rebroadcast)”, participants will be able to: Describe uncommon causes of unexplained abdominal pain; Recognise acute hepatic porphyria (AHP) in patients with severe abdominal pain; and Discuss the importance of random (spot) urine testing in patients with suspected AHP.
Ffion Davies, MBChB, FRCPCH, FRCEM - Managing Major Bleeding in Patients Receiving DOACs: Data, Developments, and Decision-Making in the ED
1y ago · 47:22
Visit https://www.peervoice.com/SYP860 to view the entire programme with slides. After completing “Ffion Davies, MBChB, FRCPCH, FRCEM - Managing Major Bleeding in Patients Receiving DOACs: Data, Developments, and Decision-Making in the ED”, participants will be able to: Evaluate current guidance for management of life-threatening bleeding in patients receiving direct oral anticoagulants (DOACs) who present to the emergency department (ED); Assess current evidence from clinical trials and real-world studies related to use of targeted reversal or repletion strategies for life-threatening bleedin
Deborah Siegal, MD, MSc, FRCPC / Richard Body, MBChB, FRCEM, PhD - Turn the Bleed Around: Expert Perspectives on the Evolving Evidence for Management of Factor Xa Inhibitor-Associated Life-Threatening Bleeding
1y ago · 28:23
Visit https://www.peervoice.com/GHB860 to view the entire programme with slides. After completing “Deborah Siegal, MD, MSc, FRCPC / Richard Body, MBChB, FRCEM, PhD - Turn the Bleed Around: Expert Perspectives on the Evolving Evidence for Management of Factor Xa Inhibitor-Associated Life-Threatening Bleeding”, participants will be able to: Evaluate current guideline recommendations for management of life-threatening bleeding associated with anticoagulation use; Assess data from clinical trials and real-world studies related to specific anticoagulation reversal strategies for factor Xa-associate
Marwan Fakih, MD - The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Second Line
2y ago · 28:14
Visit https://www.peervoice.com/SSC860 to view the entire programme with slides. After completing “Marwan Fakih, MD - The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Second Line”, participants will be able to: Identify patients with advanced colorectal cancer (CRC) with disease progression who should be treated with later lines of therapy; Recognize patient-specific characteristics which guide choice and planning of later lines of treatment for advanced CRC; and Propose treatment regimens for patients with advanced CRC which has progressed on earlier lines of therapy
Marwan Fakih, MD - Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC
2y ago · 32:30
Visit https://www.peervoice.com/AQR860 to view the entire programme with slides. After completing “Marwan Fakih, MD - Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC”, participants will be able to: Describe current evidence-based standards of care in the management of advanced colorectal cancer (CRC); Evaluate emerging efficacy and safety data for treatment of advanced CRC beyond the second line; and Apply clinical data and guidelines to individualized sequencing of lines of therapy in advanced CRC.
Philip James Tozer, MBBS, MD(Res), FRCS - Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring the Who, When, and How for Stem Cell Therapy
2y ago · 33:16
Visit https://www.peervoice.com/GWC860 to view the entire programme with slides. After completing “Philip James Tozer, MBBS, MD(Res), FRCS - Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring the Who, When, and How for Stem Cell Therapy”, participants will be able to: Evaluate efficacy and safety outcomes for advanced therapies, including stem cell therapy, which guide their incorporation into treatment plans for patients with complex perianal fistulas (CPF) due to Crohn’s disease (CD); Identify the role of magnetic resonance imaging in the assessment of CPF and trea
Angela Lamarca, MD, PhD, MSc - Overcoming Barriers to Better Care in CCA: Keys to Optimising Multidisciplinary Care, Molecular Testing, and Targeted Treatment
2y ago · 37:13
Visit https://www.peervoice.com/CPJ860 to view the entire programme with slides. After completing “Angela Lamarca, MD, PhD, MSc - Overcoming Barriers to Better Care in CCA: Keys to Optimising Multidisciplinary Care, Molecular Testing, and Targeted Treatment”, participants will be able to: Apply guideline recommendations for molecular testing and targeted treatment in patients with cholangiocarcinoma (CCA); Propose practical approaches for improved multidisciplinary team communication and collaboration across the care continuum for CCA; and Identify strategies to overcome common barriers to opt
Andreas Kremer, MD, PhD, MHBA - Initiating the Conversation on Itch: Modelling Best Practices in Patient-Centred Care for Cholestatic Pruritus in PBC
2y ago · 23:48
Visit https://www.peervoice.com/TKB860 to view the entire programme with slides. After completing “Andreas Kremer, MD, PhD, MHBA - Initiating the Conversation on Itch: Modelling Best Practices in Patient-Centred Care for Cholestatic Pruritus in PBC”, participants will be able to: Describe the impact of uncontrolled cholestatic pruritus on patient quality of life, mental health, and overall outcomes in primary biliary cholangitis (PBC); Summarise key patient counselling and education points related to cholestatic pruritus in PBC; and Incorporate effective communication and information-gathering
Andreas Kremer, MD, PhD, MHBA - Incorporating the Investigation of Itch Into the Patient Care Process for PBC: Practical Steps, Tips, and Tools
2y ago · 23:05
Visit https://www.peervoice.com/KQF860 to view the entire programme with slides. After completing “Andreas Kremer, MD, PhD, MHBA - Incorporating the Investigation of Itch Into the Patient Care Process for PBC: Practical Steps, Tips, and Tools”, participants will be able to: Recognise the consequences of uncontrolled cholestatic pruritus on quality of life and outcomes in patients with primary biliary cholangitis (PBC); Demonstrate ability to use effective strategies when discussing and evaluating cholestatic pruritus in patients with PBC; and Evaluate both current and novel investigational str
Arndt Vogel, MD - Modern Management of Cholangiocarcinoma: Sharing Evidence, Experience, and Expertise
3y ago · 1:15:33
Visit https://www.peervoice.com/CSV860 to view the entire programme with slides. After completing “Arndt Vogel, MD - Modern Management of Cholangiocarcinoma: Sharing Evidence, Experience, and Expertise”, participants will be able to: Identify the role of molecular testing in guiding treatment options and decision-making for patients with cholangiocarcinoma (CCA); Apply recommended strategies to facilitate timely and accurate molecular testing and evidence-based treatment of patients with CCA; and Use a multidisciplinary approach to overcome key barriers to testing and treatment of patients wit
Geoffrey Ku, MD - Here’s The Challenge! Overcoming Tumour Heterogeneity in Gastric/GEJ Cancers
3y ago · 20:56
Visit https://www.peervoice.com/QKT860 to view the entire programme with slides. After completing “Geoffrey Ku, MD - Here’s The Challenge! Overcoming Tumour Heterogeneity in Gastric/GEJ Cancers”, participants will be able to: Summarise the latest testing guidelines for HER2 expression in gastric/gastroesophageal junction (GEJ) cancer; Discuss the rationale for repeat tumour biopsies in patients with advanced gastric/GEJ cancer who have progressed on first-line treatment; and Use effective, evidence-based treatment strategies to maximise patient outcomes on second-line therapy for patients with
Nick Pavlakis, MBBS, PLD / Kohei Shitara, MD - The Evolution of Treatment for Advanced Gastric and Oesophageal Cancers: New Insights From Key Congresses
3y ago · 25:56
Visit https://www.peervoice.com/PHC860 to view the entire programme with slides. After completing “Nick Pavlakis, MBBS, PLD / Kohei Shitara, MD - The Evolution of Treatment for Advanced Gastric and Oesophageal Cancers: New Insights From Key Congresses”, participants will be able to: Recognise the unmet needs in patients with advanced gastric and oesophageal cancers and the role of emerging data related to targeted treatments, immunotherapy, and combinations in addressing these unmet needs; Describe key efficacy and safety data for targeted therapies, including multikinase inhibitors and immuno
Tanios Bekaii-Saab, MD - Expert Perspectives on Treatment Sequencing in Advanced CRC: Keys to Reaching Later Lines of Therapy
3y ago · 30:06
Visit https://www.peervoice.com/MZU860 to view the entire programme with slides. After completing “Tanios Bekaii-Saab, MD - Expert Perspectives on Treatment Sequencing in Advanced CRC: Keys to Reaching Later Lines of Therapy”, participants will be able to: Apply evidence-based and expert-recommended approaches to sequencing of treatment for patients with advanced colorectal cancer (CRC); Propose treatment plans for patients with advanced CRC based on current efficacy and safety data, as well as individual patient characteristics; and Evaluate emerging data for novel treatment approaches for ad

Episodes

Reading the feed…

Also on peervoice.com

More Science shows

Arizona Science

azpm.org

510 episodes · 9d ago

WiTcast

witcastthailand.com

357 episodes · 8d ago

Evrim Ağacı ile Bilime Dair Her Şey!

evrimagaci.org

557 episodes · 8d ago

A Moment of Science

prxu.org

1,000 episodes · 9d ago

Groks Science Radio Show and Podcast

ocf.berkeley.edu

1,000 episodes · 11d ago

Ask the Naked Scientists

thenakedscientists.com

802 episodes · 9d ago

PeerVoice Digestive Diseases Audio

Episodes 40

Hannele Yki-Järvinen, MD, FRCP - Recognising and Referring Individuals With MASH: Practical Pathways for Our Endocrinology Practices

One Disease, Many Clinical Presentations: Why and How to Spot Acute Hepatic Porphyria in Different Healthcare Settings

John Friedewald, MD, FASN, FAST - Breakthroughs and Buzz From Boston: Key Takeaways for the Kidney Transplant Community

Sven Francque, MD, PhD - The Gastroenterologist’s Guide to Finding and Managing MASH With Fibrosis: Practical Strategies for Everyday Practice

Javier Ampuero, MD, PhD - Making MASH a Priority in Our Gastroenterology Practices: Why We Should and How We Can

Jörn M. Schattenberg, MD - Cases in Contemporary MASH Management: Expert Insights on the Practical Integration of Disease-Specific Pharmacotherapy

Naim Alkhouri, MD, FAASLD, DABOM - Don’t Wait, and Look Beyond Weight: The Growing Case for Urgent and Comprehensive Management of MASH

Kris V. Kowdley, MD - Advancing the Management of Cholestatic Liver Disease: Optimizing Treatment Pathways and Novel Therapies

Marla C. Dubinsky, MD / David T. Rubin, MD - TNF Inhibitors in Inflammatory Bowel Disease: How Can We Realize Opportunities to Optimize Clinical and Patient Outcomes?

Albrecht Stenzinger, MD - Optimising the Molecular Profiling Journey for Patients With CCA: Applying Best Practices and Avoiding Pitfalls

Olivier Bonnot, MD, PhD - Acute Psychosis: When to Suspect Acute Hepatic Porphyria

Darren M. Brenner / Benoît Coffin - If I'd Known Then What I Know Now: Recognising My First AHP Patient

Darren M. Brenner, MD - If I'd Known Then What I Know Now: Recognising My First AHP Patient (Rebroadcast)

Ffion Davies, MBChB, FRCPCH, FRCEM - Managing Major Bleeding in Patients Receiving DOACs: Data, Developments, and Decision-Making in the ED

Deborah Siegal, MD, MSc, FRCPC / Richard Body, MBChB, FRCEM, PhD - Turn the Bleed Around: Expert Perspectives on the Evolving Evidence for Management of Factor Xa Inhibitor-Associated Life-Threatening Bleeding

Marwan Fakih, MD - The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Second Line

Marwan Fakih, MD - Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC

Philip James Tozer, MBBS, MD(Res), FRCS - Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring the Who, When, and How for Stem Cell Therapy

Angela Lamarca, MD, PhD, MSc - Overcoming Barriers to Better Care in CCA: Keys to Optimising Multidisciplinary Care, Molecular Testing, and Targeted Treatment

Andreas Kremer, MD, PhD, MHBA - Initiating the Conversation on Itch: Modelling Best Practices in Patient-Centred Care for Cholestatic Pruritus in PBC

Andreas Kremer, MD, PhD, MHBA - Incorporating the Investigation of Itch Into the Patient Care Process for PBC: Practical Steps, Tips, and Tools

Arndt Vogel, MD - Modern Management of Cholangiocarcinoma: Sharing Evidence, Experience, and Expertise

Geoffrey Ku, MD - Here’s The Challenge! Overcoming Tumour Heterogeneity in Gastric/GEJ Cancers

Nick Pavlakis, MBBS, PLD / Kohei Shitara, MD - The Evolution of Treatment for Advanced Gastric and Oesophageal Cancers: New Insights From Key Congresses

Tanios Bekaii-Saab, MD - Expert Perspectives on Treatment Sequencing in Advanced CRC: Keys to Reaching Later Lines of Therapy

Episodes

Also on peervoice.com

PeerVoice Internal Medicine Video

PeerVoice Internal Medicine Audio

PeerVoice Clinical Pharmacology Video

PeerVoice Oncology & Haematology Video

PeerVoice Clinical Pharmacology Audio

PeerVoice Oncology & Haematology Audio

More Science shows

Arizona Science

WiTcast

Evrim Ağacı ile Bilime Dair Her Şey!

A Moment of Science

Groks Science Radio Show and Podcast

Ask the Naked Scientists

Episodes 40

Hannele Yki-Järvinen, MD, FRCP - Recognising and Referring Individuals With MASH: Practical Pathways for Our Endocrinology Practices

One Disease, Many Clinical Presentations: Why and How to Spot Acute Hepatic Porphyria in Different Healthcare Settings

John Friedewald, MD, FASN, FAST - Breakthroughs and Buzz From Boston: Key Takeaways for the Kidney Transplant Community

Sven Francque, MD, PhD - The Gastroenterologist’s Guide to Finding and Managing MASH With Fibrosis: Practical Strategies for Everyday Practice

Javier Ampuero, MD, PhD - Making MASH a Priority in Our Gastroenterology Practices: Why We Should and How We Can

Jörn M. Schattenberg, MD - Cases in Contemporary MASH Management: Expert Insights on the Practical Integration of Disease-Specific Pharmacotherapy

Naim Alkhouri, MD, FAASLD, DABOM - Don’t Wait, and Look Beyond Weight: The Growing Case for Urgent and Comprehensive Management of MASH

Kris V. Kowdley, MD - Advancing the Management of Cholestatic Liver Disease: Optimizing Treatment Pathways and Novel Therapies

Marla C. Dubinsky, MD / David T. Rubin, MD - TNF Inhibitors in Inflammatory Bowel Disease: How Can We Realize Opportunities to Optimize Clinical and Patient Outcomes?

Albrecht Stenzinger, MD - Optimising the Molecular Profiling Journey for Patients With CCA: Applying Best Practices and Avoiding Pitfalls

Olivier Bonnot, MD, PhD - Acute Psychosis: When to Suspect Acute Hepatic Porphyria

Darren M. Brenner / Benoît Coffin - If I'd Known Then What I Know Now: Recognising My First AHP Patient

Darren M. Brenner, MD - If I'd Known Then What I Know Now: Recognising My First AHP Patient (Rebroadcast)

Ffion Davies, MBChB, FRCPCH, FRCEM - Managing Major Bleeding in Patients Receiving DOACs: Data, Developments, and Decision-Making in the ED

Deborah Siegal, MD, MSc, FRCPC / Richard Body, MBChB, FRCEM, PhD - Turn the Bleed Around: Expert Perspectives on the Evolving Evidence for Management of Factor Xa Inhibitor-Associated Life-Threatening Bleeding

Marwan Fakih, MD - The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Second Line

Marwan Fakih, MD - Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC

Philip James Tozer, MBBS, MD(Res), FRCS - Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring the Who, When, and How for Stem Cell Therapy

Angela Lamarca, MD, PhD, MSc - Overcoming Barriers to Better Care in CCA: Keys to Optimising Multidisciplinary Care, Molecular Testing, and Targeted Treatment

Andreas Kremer, MD, PhD, MHBA - Initiating the Conversation on Itch: Modelling Best Practices in Patient-Centred Care for Cholestatic Pruritus in PBC

Andreas Kremer, MD, PhD, MHBA - Incorporating the Investigation of Itch Into the Patient Care Process for PBC: Practical Steps, Tips, and Tools

Arndt Vogel, MD - Modern Management of Cholangiocarcinoma: Sharing Evidence, Experience, and Expertise

Geoffrey Ku, MD - Here’s The Challenge! Overcoming Tumour Heterogeneity in Gastric/GEJ Cancers

Nick Pavlakis, MBBS, PLD / Kohei Shitara, MD - The Evolution of Treatment for Advanced Gastric and Oesophageal Cancers: New Insights From Key Congresses

Tanios Bekaii-Saab, MD - Expert Perspectives on Treatment Sequencing in Advanced CRC: Keys to Reaching Later Lines of Therapy